Loading clinical trials...
Loading clinical trials...
The study objective is to compare neurodevelopmental (ND) and behavioral outcomes between children with Down syndrome (DS) who had complete atrioventricular septal defect (CAVSD) repair and children from the same clinical sites with DS without major congenital heart disease (CHD) requiring previous or planned CHD surgery.
We are conducting a multicenter cohort study, ancillary to the Pediatric Heart Network (PHN) Residual Lesion Score (RLS) study, to investigate determinants of ND and behavioral outcomes in children with DS, focusing on the role of CHD surgery. We are including children with DS who had CAVSD repair, as this group comprises 91% of all children with DS in the RLS Study, with similar underlying congenital cardiac defect and surgical repair complexity, allowing our children with DS and CHD to be a homogeneous group. Moreover, one in five individuals with DS is born with an AVSD, a 2000 times higher incidence than in those with normal chromosomes. In addition to recruiting children with DS who had CAVSD repair, we will recruit similarly-aged children with DS who do not have documented major CHD (i.e., CHD requiring previous or planned CHD surgery) to come into the same PHN site for a single study visit consisting of detailed phenotyping by completion of a Health \& Developmental History Intake form, ND and behavioral assessments, and optional collection and storage of saliva specimens in the PHN Biorepository. By building our sample from RLS Study participants and recruiting additional children who had infant CAVSD repair and meet study eligibility criteria, as well as a comparison group from the same PHN sites, we are leveraging rich prospective data in a group of DS children with CAVSD repair from a nationally representative sample, and the expertise of the PHN and Boston Children's Hospital (BCH).
Age
5 - 12 years
Sex
ALL
Healthy Volunteers
Yes
Alfred I. duPont Hospital for Children
Wilmington, Delaware, United States
Children's National Hospital
Washington D.C., District of Columbia, United States
Children's Healthcare of Atlanta at Egleston
Atlanta, Georgia, United States
Riley Children's Hospital
Indianapolis, Indiana, United States
Boston Children's Hospital
Boston, Massachusetts, United States
University of Michigan Health System/Mott Hospital
Ann Arbor, Michigan, United States
Children's Mercy Hospital
Kansas City, Missouri, United States
Columbia College of Physicians and Surgeons
New York, New York, United States
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, United States
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
Start Date
May 1, 2022
Primary Completion Date
December 31, 2023
Completion Date
December 31, 2023
Last Updated
January 11, 2024
273
ACTUAL participants
Stanford Binet Intelligence Scales, Fifth Edition
OTHER
Vineland Adaptive Behavior Scales Third Edition
OTHER
Peabody Picture Vocabulary Test, Fifth Edition
OTHER
Expressive Vocabulary Test, Third Edition
OTHER
Leiter International Performance Scale, Third Edition
OTHER
Social Communication Questionnaire, Current Form
OTHER
Aberrant Behavior Checklist
OTHER
Repetitive Behavior Scale, Revised
OTHER
Lead Sponsor
Carelon Research
Collaborators
NCT05647213
NCT07042334
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions